1. Introduction {#sec0005}
===============

Because the usage of extended criteria for donation of liver transplantation has been needed due to donor organ scarcity for transplantation [@bib0005], liver grafts from marginal donors including liver with benign tumors have been accepted as treatment options. Hepatic hemangioma is one of the most common benign tumors of the liver, as described up to 7% in autopsy findings [@bib0010].

The hemangioma usually remains asymptomatic [@bib0015] and has a benign course [@bib0020], [@bib0025], [@bib0030], although symptomatic hemangiomas may rarely require either interventional or surgical treatment [@bib0035], [@bib0040], [@bib0045]. There are few published reports regarding liver transplantation using liver allografts with hemangiomas [@bib0050], [@bib0055], [@bib0060], [@bib0065], [@bib0070], [@bib0075], [@bib0080]. In not only deceased donor liver transplantation but also living donor liver transplantation (LDLT), liver allografts with hemangiomas have been utilized for transplantation. However, in LDLT setting, there are only two published reports about liver allografts with hemangioma, and they were both liver transplants for pediatric recipients [@bib0060], [@bib0075]. Until now, there has been no report in adult-to-adult LDLT with liver grafts with hemangioma.

We present here the first report of successful adult-to-adult LDLT using liver allograft with hemangioma.

2. Presentation of case {#sec0010}
=======================

A 19-year-old male was admitted with liver failure due to congenital hepatic fibrosis. A prior diagnosis of congenital hepatic fibrosis had been established by gastroenterologists before 13 years. His liver function deteriorated progressively, with the following laboratory findings: serum total bilirubin 25.2 mg/dl, prothrombin time-international normalized ratio 1.78, aspartate aminotransaminase 119 IU/l, and alanine aminotransferase 71 IU/l. No rupture of esophageal and gastric varices was seen. However, he had some critical episodes of grade 2 hepatic encephalopathy, and intensive cares including plasma exchange was seriously required. The preoperative liver profile was evaluated as Child-Pugh classification of grade C (11 points) and an MELD (Model for End Stage Liver Disease) score of 34 points.

A 45-year-old male was evaluated as a living donor for his son. The liver function tests of the donor were totally within the normal range with no evidence of any coagulopathy. Donor preoperative computed tomography and magnetic resonance imaging revealed 20 mm and 7 mm hemangiomas, at segment 2 (S2) and 4 respectively ([Fig. 1](#fig0005){ref-type="fig"}). Estimated left lobe volume with the caudate was 503 ml. Considering the anatomical relationship of S2 hemangioma and Glisson 2, liver graft was designed as the left lobe graft with caudate lobe excluded S2 hemangioma by partial resection ([Fig. 2](#fig0010){ref-type="fig"}). Estimated graft volume after hemangioma partial resection was 482 ml, which accounted for 0.83% of graft recipient weight ratio (GRWR).

Thus, the recipient status was an end-stage liver disease (i.e., advanced liver cirrhosis), and this donor was only a candidate for this recipient. After an approval of institutional ethical committee, we scheduled LDLT for this case.

A LDLT donor and recipient procedure was performed as described elsewhere [@bib0085], [@bib0090]. At the beginning of living donor operation, in vivo partial hepatic resection of the S2 hemangioma was performed without the Pringle maneuver. Intraoperative ultrasonography was used to identify the location of S2 hemangioma and Glisson 2 to avoid the injury to Glisson 2 structures ([Fig. 3](#fig0015){ref-type="fig"}A). The resected specimen from the donor liver was confirmed to be a cavernous hemangioma by an intraoperative pathologic examination, and then, the left hepatic graft with caudate lobe was harvested. The donor operation time was 521 min, and the bleeding volume of the donor operation was 1250 ml, but most of the bleeding occurred after the resection of the hemangioma. The actual liver graft weight was 504 g, and resulting in an actual GRWR of 0.90%.

The recipient operation was performed with standard procedures. At the time of reperfusion, no bleeding was observed from the resection site of S2 hemangioma ([Fig. 3](#fig0015){ref-type="fig"}B). Splenectomy was added in this case, because of the existence of splenic artery aneurysm. Recipient operation time was 632 min, and blood loss was 5320 ml.

The donor's postoperative course was almost uneventful, and he was discharged from the hospital on the post-operative day (POD) 12. The recipient was discharged from the hospital on POD 31 without subsequent liver necrosis or bile leakage from the resection site of S2 hemangioma. However, on POD 39, the recipient was re-admitted to the hospital because of the intra-abdominal bleeding, and urgent operation was performed for hemostasis. The cause of bleeding was gastric varix rupture close to splenectomy site, and there was no bleeding sign from the resection site of S2 hemangioma. He was discharged from hospital 8 weeks after the second operation with good general condition and liver graft function. He is currently doing well 2 years after the LDLT. Also, the recipient's CT scans on the post-operative 132 days and 19 months showed that the good regeneration of the liver graft without any recurrence or growth of hemangioma ([Fig. 4](#fig0020){ref-type="fig"}).

3. Discussion {#sec0015}
=============

Although liver transplantation has been widely performed for end-stage liver failure, organ shortage is the greatest problem facing the field of organ transplantation today. Therefore, the usage of extended criteria donors for organ transplantation has become a necessity due to donor organ scarcity for transplantation [@bib0005]. Actually, the use of marginal or expanded pool donors was shown to have outcome similar to ideal liver graft [@bib0095]. In renal transplantation, Khurram et al. reported that use of kidneys after tumor resection seems a feasible source to increase the donor pool [@bib0100]. Thus, it is extremely important to try to use a novel donor source as a further option to increase the number of patients who might be able to receive a liver transplantation as well as kidney transplantation.

Hepatic hemangioma is one of the most common hepatic tumors. The Mayo Clinic team suggested that most liver hemangioma could be observed safely [@bib0020], and Farges et al. confirmed the statement [@bib0025]. However, there are few published reports regarding liver transplantation using liver allografts with hemangioma so far.

As shown in [Table 1](#tbl0005){ref-type="table"}, seven cases of donor livers with hemangiomas have been reported previously [@bib0050], [@bib0055], [@bib0060], [@bib0065], [@bib0070], [@bib0075], [@bib0080]. There are only two reports of left lateral segment from a living donor containing hemangioma transplanted to pediatric patients but not to adult patients [@bib0060], [@bib0075]. While Sun et al. indicated adult-to-adult liver transplantation of an otherwise discarded partial liver allograft with a cavernous hemangioma [@bib0080], there has been no report about adult-to-adult LDLT using liver allograft with a cavernous hemangioma. To our knowledge, this is the first case demonstrating adult-to-adult liver transplantation using left hepatic lobe graft with caudate lobe after the resection of hemangioma from a living donor.

Sanada et al. have proposed a strategy for the usage of liver allograft with hemangiomas in pediatric LDLT settings [@bib0075]. They proposed that the resection of hemangiomas depends on the tumor location, the estimated graft liver volume to standard liver volume (GV/SLV) ratio after the tumor resection, and the tumor size. Hemangiomas at a peripheral location and the estimated GV/SLV ratio of 40% and more after the tumor resection are considered to be an indication of surgical resection. Similar to their proposal, we resected the 20 mm hemangioma of S2, because the hemangioma was relatively larger at peripheral site, and the estimated GRWR, which we use instead of GV/SLV ratio, after the resection of S2 hemangioma was 0.83%. On the other hand, smaller 7 mm hemangioma at S4 was not resected because the location was relatively central and the size was smaller. The size and feature of the hemangioma in the transplanted liver should be strictly followed, because detailed long-termed analysis of liver allograft with hemangioma has not been performed and a possibility of symptomatic changes may remain.

Technically speaking, in order to resect the hemangioma, there are two surgical procedures, backtable resection [@bib0050], [@bib0055] or in vivo resection in the donor surgery [@bib0075]. We chose in vivo resection during the donor operation, because we believe that in vivo procedure contains the easier anatomical resection of the tumor and the shorter cold ischemic time than backtable resection.

4. Conclusions {#sec0020}
==============

Our case is the first report of adult-to-adult transplantation using a living donor liver graft after the resection of hemangioma. Based on our experience, donor liver with hemangioma can be safely used even for adult-to-adult LDLT, while the follow-up is needed in case of the hemangioma remained in the transplanted liver. We advocate that liver allografts with hemangiomas should not be considered as a contraindication for adult-to-adult LDLT, and can be accepted as a potential liver allograft.
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![Preoperative contrast-enhanced abdominal computed tomography (A, B) and magnetic resonance imaging (C, D) of the donor liver with cavernous hemangiomas. S2 hemangioma was indicated by arrowheads, and S4 hemangioma was indicated by arrows.](gr1){#fig0005}

![The 3D-image simulation. Hemangioma was shown in H, with partial resection margin.](gr2){#fig0010}

![(A) Donor operation. Ultrasound sonogram was used to confirm the location of S2 hemangioma and Glisson 2. Location of hemangioma was indicated by white arrows. (B) Final view of recipient operation. Note no Glisson 2 injured after partial resection of hemangioma.](gr3){#fig0015}

![Post-operative CT findings in the recipient. The CT findings at 132 days (A) and at 19 months (B) were shown.](gr4){#fig0020}

###### 

Review of the documented reports of liver allografts with hemangioma.

  Case no.   Year   Author                   Reference    Deceased/living donor          Donor age   Recipient age   Hemangioma                                                           
  ---------- ------ ------------------------ ------------ ------------------------------ ----------- --------------- -------------------- ----------------------- ----------------------- --------------------------
  1          1995   Mor et al.               [@bib0050]   Deceased                       54          30              10 × 10 × 8 cm       Posterior segment       Done at backtable       Unknown
  2          2005   Onaca et al.             [@bib0055]   Deceased                       65          59              9 cm, 3 cm           Right lobe, left lobe   Done at backtable       No recurrence
  3          2005   Pacheco-Moreira et al.   [@bib0060]   Living                         32          4               4.2 cm               Lateral segment         No                      Unknown
  4          2006   Aucejo et al.            [@bib0065]   Deceased                       65          53              10 × 8 × 9           Right lobe              No                      Reduction
  5          2007   Nikeghbalian et al.      [@bib0070]   Deceased                       36          37              20% of whole liver   Right lobe              No                      Reduction
  6          2011   Sanada et al.            [@bib0075]   Living                         27          2               2 cm                 Lateral segment         Done in operation       No recurrence
  7          2013   Sun et al.               [@bib0080]   Living (otherwise discarded)   41          27              7.8 cm               Left lobe               No                      No change
  Our case   2015   Onishi et al.                         Living                         45          19              2 cm, 0.7 cm         S2, S4                  Done in operation, no   No recurrence, no change
